iScience (May 2023)

SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients

  • Benjamin Charvet,
  • Joanna Brunel,
  • Justine Pierquin,
  • Mathieu Iampietro,
  • Didier Decimo,
  • Nelly Queruel,
  • Alexandre Lucas,
  • María del Mar Encabo-Berzosa,
  • Izaskun Arenaz,
  • Tania Perez Marmolejo,
  • Arturo Ivan Gonzalez,
  • Armando Castorena Maldonado,
  • Cyrille Mathieu,
  • Patrick Küry,
  • Jose Flores-Rivera,
  • Fernanda Torres-Ruiz,
  • Santiago Avila-Rios,
  • Gonzalo Salgado Montes de Oca,
  • Jon Schoorlemmer,
  • Hervé Perron,
  • Branka Horvat

Journal volume & issue
Vol. 26, no. 5
p. 106604

Abstract

Read online

Summary: Patients with COVID-19 may develop abnormal inflammatory response, followed in some cases by severe disease and long-lasting syndromes. We show here that in vitro exposure to SARS-CoV-2 activates the expression of the human endogenous retrovirus (HERV) HERV-W proinflammatory envelope protein (ENV) in peripheral blood mononuclear cells from a subset of healthy donors, in ACE2 receptor and infection-independent manner. Plasma and/or sera of 221 COVID-19 patients from different cohorts, infected with successive SARS-CoV-2 variants including the Omicron, had detectable HERV-W ENV, which correlated with ENV expression in T lymphocytes and peaked with the disease severity. HERV-W ENV was also found in postmortem tissues of lungs, heart, gastrointestinal tract, brain olfactory bulb, and nasal mucosa from COVID-19 patients. Altogether, these results demonstrate that SARS-CoV-2 could induce HERV-W envelope protein expression and suggest its involvement in the immunopathogenesis of certain COVID-19-associated syndromes and thereby its relevance in the development of personalized treatment of patients.

Keywords